Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Varian Medical Systems and Florida Hospital, a healthcare system including 17 Florida hospitals, have formed a strategic alliance to provide a radiation therapy training site at Florida Hospital Celebration Health in Celebration, Fla.
Display provider Richardson Electronics Ltd. will offer Planar Systems Inc.'s FDA-approved flat-panel Dome C5i system for displaying and viewing digital mammograms.
So you've purchased a digital mammography system, and now what? Deploying such a system not only opens up a new world of opportunities, but also a lot of potential challenges.
As part of a three-part plan to improve medical equipment security, the U.S. Food and Drug Administration revealed that it will withhold regulatory approval on new medical devices submitted by manufacturers that do not keep up with current security patche
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
